Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood-brain barrier penetration and binding to human serum albumin.

Pérez DI, Pistolozzi M, Palomo V, Redondo M, Fortugno C, Gil C, Felix G, Martinez A, Bertucci C.

Eur J Pharm Sci. 2012 Apr 11;45(5):677-84. doi: 10.1016/j.ejps.2012.01.007. Epub 2012 Jan 28.

PMID:
22306656
2.

Tocainide analogues binding to human serum albumin: a HPLAC and circular dichroism study.

Pistolozzi M, Franchini C, Corbo F, Muraglia M, De Giorgi M, Felix G, Bertucci C.

J Pharm Biomed Anal. 2010 Oct 10;53(2):179-85. doi: 10.1016/j.jpba.2010.03.005. Epub 2010 Mar 7.

PMID:
20359840
3.

5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3.

Palomo V, Perez DI, Perez C, Morales-Garcia JA, Soteras I, Alonso-Gil S, Encinas A, Castro A, Campillo NE, Perez-Castillo A, Gil C, Martinez A.

J Med Chem. 2012 Feb 23;55(4):1645-61. doi: 10.1021/jm201463v. Epub 2012 Feb 3.

PMID:
22257026
4.

Species-dependent binding of tocainide analogues to albumin: affinity chromatography and circular dichroism study.

Pistolozzi M, Fortugno C, Franchini C, Corbo F, Muraglia M, Roy M, Félix G, Bertucci C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 1;968:69-78. doi: 10.1016/j.jchromb.2014.01.007. Epub 2014 Jan 10.

5.

Role of salt bridge(s) in the binding and photoconversion of bilirubin bound to high affinity site on human serum albumin.

Khan MM, Muzammil S, Tayyab S.

Biochim Biophys Acta. 2000 Jun 15;1479(1-2):103-13.

PMID:
11004533
6.

The location of the high- and low-affinity bilirubin-binding sites on serum albumin: ligand-competition analysis investigated by circular dichroism.

Goncharova I, Orlov S, Urbanová M.

Biophys Chem. 2013 Oct-Nov;180-181:55-65. doi: 10.1016/j.bpc.2013.06.004. Epub 2013 Jun 22.

PMID:
23838624
7.

Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives.

Castro A, Encinas A, Gil C, Bräse S, Porcal W, Pérez C, Moreno FJ, Martínez A.

Bioorg Med Chem. 2008 Jan 1;16(1):495-510. Epub 2007 Sep 14.

PMID:
17919914
8.

Reversible human serum albumin binding of lipocrine: a circular dichroism study.

Bertucci C, De Simone A, Pistolozzi M, Rosini M.

Chirality. 2011 Oct;23(9):827-32. doi: 10.1002/chir.21006. Epub 2011 Aug 25.

PMID:
21919078
9.

Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.

Collino M, Thiemermann C, Mastrocola R, Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O, Dianzani C, Aragno M, Fantozzi R.

Shock. 2008 Sep;30(3):299-307. doi: 10.1097/SHK.0b013e318164e762.

PMID:
18323734
10.

Screening of inhibitors of glycogen synthase kinase-3β from traditional Chinese medicines using enzyme-immobilized magnetic beads combined with high-performance liquid chromatography.

Li Y, Xu J, Chen Y, Mei Z, Xiao Y.

J Chromatogr A. 2015 Dec 18;1425:8-16. doi: 10.1016/j.chroma.2015.10.062. Epub 2015 Oct 27.

PMID:
26610618
11.

Bilirubin, model membranes and serum albumin interaction: The influence of fatty acids.

Novotná P, Urbanová M.

Biochim Biophys Acta. 2015 Jun;1848(6):1331-40. doi: 10.1016/j.bbamem.2015.02.026. Epub 2015 Mar 4.

12.

Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.

Cuzzocrea S, Mazzon E, Di Paola R, Muià C, Crisafulli C, Dugo L, Collin M, Britti D, Caputi AP, Thiemermann C.

Clin Immunol. 2006 Jul;120(1):57-67. Epub 2006 May 2.

PMID:
16631408
13.

Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.

Morales-Garcia JA, Palomo V, Redondo M, Alonso-Gil S, Gil C, Martinez A, Perez-Castillo A.

ACS Chem Neurosci. 2014 Mar 19;5(3):194-204. doi: 10.1021/cn400166d. Epub 2014 Jan 17.

14.

Effects of glycogen synthase kinase-3beta inhibition on the development of cerulein-induced acute pancreatitis in mice.

Cuzzocrea S, Malleo G, Genovese T, Mazzon E, Esposito E, Muià C, Abdelrahman M, Di Paola R, Thiemermann C.

Crit Care Med. 2007 Dec;35(12):2811-21.

PMID:
18074481
15.

Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.

Fang CH, Li BG, James JH, King JK, Evenson AR, Warden GD, Hasselgren PO.

Endocrinology. 2005 Jul;146(7):3141-9. Epub 2005 Mar 31.

PMID:
15802492
16.

Study of donepezil binding to serum albumin by capillary electrophoresis and circular dichroism.

Gotti R, Bertucci C, Andrisano V, Pomponio R, Cavrini V.

Anal Bioanal Chem. 2003 Nov;377(5):875-9. Epub 2003 Sep 3.

PMID:
12955395
17.

HSA binding of HIV protease inhibitors: a high-performance affinity chromatography study.

Bertucci C, Pistolozzi M, Felix G, Danielson UH.

J Sep Sci. 2009 May;32(10):1625-31. doi: 10.1002/jssc.200900051.

PMID:
19370735
18.

Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.

Ramirez SH, Fan S, Zhang M, Papugani A, Reichenbach N, Dykstra H, Mercer AJ, Tuma RF, Persidsky Y.

Am J Pathol. 2010 Feb;176(2):881-92. doi: 10.2353/ajpath.2010.090671. Epub 2010 Jan 7.

19.

Predicting both passive intestinal absorption and the dissociation constant toward albumin using the PAMPA technique.

Bujard A, Sol M, Carrupt PA, Martel S.

Eur J Pharm Sci. 2014 Oct 15;63:36-44. doi: 10.1016/j.ejps.2014.06.025. Epub 2014 Jul 4.

PMID:
25008117
20.

Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs.

Grumetto L, Russo G, Barbato F.

Mol Pharm. 2016 Aug 1;13(8):2808-16. doi: 10.1021/acs.molpharmaceut.6b00397. Epub 2016 Jul 14.

PMID:
27377191

Supplemental Content

Support Center